11986092

Source:http://linkedlifedata.com/resource/pubmed/id/11986092

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0086418, umls-concept:C0176217, umls-concept:C0205390, umls-concept:C1261333
pubmed:issue	5
pubmed:dateCreated	2002-5-2
pubmed:abstractText	To undertake a preliminary safety and performance evaluation of an artificial cornea, the Chirila Keratoprosthesis, in human patients.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7802443
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Polyhydroxyethyl Methacrylate
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0161-6420
pubmed:author	pubmed-author:ChirilaTraian VTV, pubmed-author:ConstableIan JIJ, pubmed-author:CrawfordGeoffrey JGJ, pubmed-author:HicksCelia RCR, pubmed-author:MulhollandBridgetB, pubmed-author:TanDonaldD, pubmed-author:TanS PSP, pubmed-author:VijayasekaranSarojiniS
pubmed:issnType	Print
pubmed:volume	109
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	883-9
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11986092-Cornea, pubmed-meshheading:11986092-Corneal Opacity, pubmed-meshheading:11986092-Female, pubmed-meshheading:11986092-Humans, pubmed-meshheading:11986092-Male, pubmed-meshheading:11986092-Polyhydroxyethyl Methacrylate, pubmed-meshheading:11986092-Prospective Studies, pubmed-meshheading:11986092-Prostheses and Implants, pubmed-meshheading:11986092-Prosthesis Implantation, pubmed-meshheading:11986092-Safety, pubmed-meshheading:11986092-Visual Acuity
pubmed:year	2002
pubmed:articleTitle	The Chirila Keratoprosthesis: phase I human clinical trial.
pubmed:affiliation	Lions Eye Institute and Centre for Ophthalmology and Visual Science, University of Western Australia, Perth, Australia.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase I